Elsevier

Behavioural Brain Research

Volume 197, Issue 2, 11 February 2009, Pages 457-461
Behavioural Brain Research

Short communication
Knockout of spinophilin, an endogenous antagonist of arrestin-dependent α2-adrenoceptor functions, enhances receptor-mediated antinociception yet does not eliminate sex-related differences

https://doi.org/10.1016/j.bbr.2008.09.036Get rights and content

Abstract

We have previously shown gonadal steroid-dependent, gender specific modulation of nociception by α2-adrenoceptors. Agonist activation of the receptor enhances its association with spinophilin that antagonizes arrestin functions both by diminishing receptor phosphorylation by G-protein-coupled receptor kinase 2 (GRK2) and by competing for receptor interactions with arrestin. Since spinophilin is highly enriched in dendritic spines, we investigated whether α2-adrenoceptor-induced antinociception as well as sex-related differences are modified in spinophilin knockout mice. We evaluated α2-adrenoceptor antinociception in a heat-evoked tail flick test in spinophilin wild type (Sp+/+) and knockout (Sp−/−) mice. Baseline tail flick latencies (TFLs) did not change between any groups. Interestingly, the α2-adrenoceptor agonist, clonidine, increased TFL in male and diestrous (low estrogen) Sp−/− as well as Sp+/+ mice; in fact, this increase in TFL was significantly higher in Sp−/− male and diestrous groups than in their Sp+/+ counterparts. This unexpected finding is consistent with enhanced α2-adrenoceptor–mediated sedation observed previously in Sp−/− mice, presumably due to accelerated endocytosis of desensitized receptors and recycling of refreshed receptors when arrestin is not competed for by spinophilin in Sp−/− mice. Despite modulation of α2-adrenoceptor effects in Sp−/− mice, sex-related differences were retained; thus, clonidine was ineffective in proestrous females (highest estrogen levels), in both Sp−/− and Sp+/+ mice, reaffirming that estrogen suppresses α2-adrenoceptor-evoked antinociception. These findings show that elimination of spinophilin enhances α2-adrenoceptor-evoked antinociception in estrogen-deprived physiological settings, suggesting a role for spinophilin to suppress these effects, and yet this enhanced response cannot overcome the absence of antinociception with elevated estrogen levels.

Section snippets

Acknowledgements

This study was supported by NIH grants SC1NS063951, U54 NS41071 and RR03032, and a scientist development grant from American Heart Association to Dr. Qin Wang. We thank Dr. Paul Greengard for providing the breeding pairs of Sp−/− and Sp+/+ mice.

References (38)

  • C.D. Nelson et al.

    Beta-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Ialpha promotes agonist-stimulated sequestration of the beta2-adrenergic receptor

    J Biol Chem

    (2008)
  • J.G. Richman et al.

    Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin

    J Biol Chem

    (2001)
  • E.C. Stoffel et al.

    Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats

    J Pain

    (2005)
  • A.D. Thompson et al.

    Sex-specific modulation of spinal nociception by alpha(2)-adrenoceptors: Differential regulation by estrogen and testosterone

    Neuroscience

    (2008)
  • P.B. Allen et al.

    Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines

    Proc Natl Acad Sci USA

    (1997)
  • A. Amandusson et al.

    Colocalization of oestrogen receptor immunoreactivity and preproenkephalin mRNA expression to neurons in the superficial laminae of the spinal and medullary dorsal horn of rats

    Eur J Neurosci

    (1996)
  • M.A. Ansonoff et al.

    Receptor phosphorylation mediates estradiol reduction of alpha2-adrenoceptor coupling to G protein in the hypothalamus of female rats

    Endocrine

    (2001)
  • K.J. Berkley

    Sex differences in pain

    Behav Brain Sci

    (1997)
  • A.E. Brady et al.

    Alpha 2-adrenergic agonist enrichment of spinophilin at the cell surface involves beta gamma subunits of Gi proteins and is preferentially induced by the alpha 2A-subtype

    Mol Pharmacol

    (2005)
  • View full text